Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition.
about
The Role of CC-Chemokines in the Regulation of AngiogenesisInflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applicationsContrasting in vitro vs. in vivo effects of a cell membrane-specific CC-chemokine binding protein on macrophage chemotaxis.Chemokine receptor CCR5: from AIDS to atherosclerosisCytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.Cytokines: roles in atherosclerosis disease progression and potential therapeutic targetsChemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-/- miceHydrodynamic Gene Delivery of CC Chemokine Binding Fc Fusion Proteins to Target Acute Vascular Inflammation In Vivo.Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.Macrophage heterogeneity in atherosclerotic plaques.Broad-Spectrum Inhibition of the CC-Chemokine Class Improves Wound Healing and Wound Angiogenesis.Immunomodulating Drugs Based on Poxviral Proteins.Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockade.Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.Improved Lentiviral Gene Delivery to Mouse Liver by Hydrodynamic Vector Injection through Tail Vein
P2860
Q28077024-B4C84033-2C52-4A53-A05E-C9A20E2DA409Q28275259-3B311865-A26F-450B-B618-0B5B54AD7A65Q34387703-D9F8335E-D1BA-4BCA-A4FF-8CBC4FA1B2EFQ34672038-3623B289-EDF0-4183-A0BD-B0C1E2585490Q35640438-CF1C40D2-7F43-4725-8A0E-8A4CE0EF0F88Q36064353-9130F4CE-1EEF-413F-816D-4325D9E8EA5BQ36304258-E22D413F-A5AE-44BA-8513-02266B3EFC10Q36333599-C4C8026D-8031-436F-A2D8-C6623556AE0AQ37470294-60079FF0-D1F2-41B6-B36A-D01E6673518DQ37594434-6E691234-568C-4358-9A2D-25C4428B0036Q37631612-9BFAF44F-6DEF-4CA6-BC22-24053A4E8B3CQ38715016-BE09881B-19EF-41FA-9C93-9DFF174A3101Q41774423-45180C74-7EC6-4392-A311-B22FFD06D48CQ53669187-B9078512-FC02-449E-BC92-E7426CA0C556Q58799285-67909DF4-4470-4CF3-9522-F12E007E83B9
P2860
Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Lentiviral gene transfer to re ...... -term CC-chemokine inhibition.
@en
Lentiviral gene transfer to re ...... -term CC-chemokine inhibition.
@nl
type
label
Lentiviral gene transfer to re ...... -term CC-chemokine inhibition.
@en
Lentiviral gene transfer to re ...... -term CC-chemokine inhibition.
@nl
prefLabel
Lentiviral gene transfer to re ...... -term CC-chemokine inhibition.
@en
Lentiviral gene transfer to re ...... -term CC-chemokine inhibition.
@nl
P2093
P50
P356
P1433
P1476
Lentiviral gene transfer to re ...... g-term CC-chemokine inhibition
@en
P2093
P2888
P304
P356
10.1038/GT.2008.141
P577
2008-09-18T00:00:00Z
P5875
P6179
1020671861